A new treatment for von Willebrand's syndrome.
D000347:Afibrinogenemia / Q000188:drug therapy; D002648:Child; D005169:Factor VIII; D006467:Hemophilia A / Q000188:drug therapy; D002836:Hemophilia B / Q000188:drug therapy; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use*; D008297:Male; D008656:Mestranol / Q000627:therapeutic use*; D014842:von Willebrand Diseases / Q000188:drug therapy*
D005169:Factor VIII; D008656:Mestranol; D008234:Lynestrenol